Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR)

International Journal of Cancer

Volumn 78, Issue 1, 1998, Pages 53-61

  DiPietrantonio, Anna M ^a   Hsieh, Tze Chen ^a   Olson, Susan C ^a   Joseph, M W U ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CYCLIN D1; CYCLIN DEPENDENT KINASE; DIACYLGLYCEROL; DNA; FENRETINIDE; FUMONISIN B1; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; RETINOBLASTOMA PROTEIN; RETINOIC ACID; SPHINGOSINE ACYLTRANSFERASE; ANTINEOPLASTIC AGENT; CARBOXYLIC ACID; CARCINOGEN; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 4; DNA FRAGMENT; FUMONISIN; ONCOPROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CELL STRAIN HL 60; DRUG EFFECT; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TIME;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CARBOXYLIC ACIDS; CARCINOGENS, ENVIRONMENTAL; CERAMIDES; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DIGLYCERIDES; DNA FRAGMENTATION; DNA, NEOPLASM; FENRETINIDE; FUMONISINS; G1 PHASE; HL-60 CELLS; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; S PHASE; TIME FACTORS;

EID: 0031595243     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6     Document Type: Article

References (39)

1. 1 on phosphoethanolamine biosynthesis in Chinese hamster ovary cells. Biochim. biophys. Acta, 1304, 190-196 (1996).
2. CHAN, L.N., ZHANG, S., SHAO, J., WAIKEL, R., THOMPSON, E.A. and CHAN, T.S., N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells. Leukemia Lymphoma, 25, 271-280 (1997).
3. CIFONE, M.G., DE MARIA, R., RONCAIOLI, P., RIPPO, M.R., AZUMA, M., LANIER, L.L., SANTONI, A. and TESTI, R., Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. exp. Med., 177, 1547-1552 (1994).
4. CONNAWAY, C.C., JIAO, D., KELLOFF, G.J., STEELE, V.E., RIVENSON, A. and CHUNG, F.L., Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl)retinamide and beta-carotene for tobacco-nitrosamineinduced lung tumors in A/J mice. Cancer Lett., 124, 85-93 (1998).
5. COSTA, A., FORMELLI, F., CHIESA, F., DECENSI, A., DE PALO, G. and VERONESI, U., Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res, 54, 2032S-2037S.
6. DBAIBO, G.S., OBEID, L.M. and HANNUN, Y.A., Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. J. biol. Chem., 268, 17762-17766 (1993).
7. DEGOS, L., Retinoic acid in acute promyelocytic leukemia: a model for differentiation therapy. Curr. Opin. Oncol., 4, 45-52 (1992).
8. DELIA, D., AIELLO, A., FORMELLI, F., FONTANELLA, E., COSTA, A., MIYASHITA, T., REED, J.C. and PIEROTTI, M.A., Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)retinainide and effect of deregulated bcl-2. Blood., 85, 359-367 (1995).
9. cdc2, bcl-2 and actin expression in the human promyelocytic HL-60 leukemic cells. Biochem. biophys. Res. Comm., 224, 837-842 (1996).
10. DI VINCI, A., GEIDO, E., INFUSINI, E. and GIARETTI, W., Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Int. J. Cancer, 59, 422-426 (1994).
11. DOBROWSKY, R.T., KAMABIYASHI, C., MUMBY, M.C. and HANNUN, Y.A., Ceramide activates heterotrimeric protein phosphatase 2A. J. biol. Chem., 268, 15523-15530 (1993).
12. GREENBERG, E.R. and SPORN, M.B., Antioxidant vitamins, cancer, and cardiovascular disease. N. Engl. J. Med., 334, 1189-1190 (1996).
13. GREENWALD, P., KRAMER, B. and WEED, D., Expanding horizons in breast and prostate cancer prevention and early detection. J. Cancer Educ., 8, 91-107 (1993).
14. HANNUN, Y.A., The sphingomyelin cycle and second messenger function of ceramide. J. biol. Chem., 269, 3125-3128 (1994).
15. HASEGAWA, J., KAMADA, S., KAMIIKE, W., SHIMIZU, S., IMAZU, T., MATSUDA, H. and TSUJIMOTO, Y., Involvement of CPP32/Yama9-like protease in Fas-mediated apoptosis. Cancer Res., 56, 1713-1718 (1996).
16. HONG, W.K. and SPORN, M.B., Recent advances in chemoprevention of cancer. Science, 278, 1073-1077 (1997).
17. JOSEPH, C.K., BYUN, H.S., BITTMAN, R. and KOLESNICK, R.N., Substrate recognition by ceramide-activated protein kinase. J. biol. Chem., 268, 20002-20006 (1993).
18. KAUFMANN, S.H., DESNOYERS, S., OTTAVIO, Y., DAVIDSON, N.E. and POIRER, G.G., Specific proteolytic cleavage of Poly(ADP-ribose) polymerase: an early marker of chemotherapy induced apoptosis. Cancer Res., 53, 3976-3985 (1993).
19. KAZMI, S.M.I., PLANTE, R.K., VISCONTI, V. and LAU, C.Y., Comparison of N-(4-hydroxyphenyl) retinamide and all-trans-retinoic acid in the regula tion of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res., 56, 1056-1062 (1996).
20. KELLOFF, G.J., CROWELL, J.A., BOONE, C.W., LUBET, R.A., GREENWALD, P., ALBERTS, D.S., COVEY, J.M., DOODY, L.A. and KNAPP, G.G., Clinical development plan: N-(4-hydroxyphenyl)retinamide. J. Cell. Biochem. (Suppl. 20), 176-196 (1994).
21. KIENTA, K.J., ESPER, P.S., ZWAS, F., KRZEMINSKI, R. and FLAHERTY, L.E., Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate. Amer. J. Clin. Oncol., 20, 36-39 (1997).
22. LIPPMAN, S.M., KESSLER, J.F. and MEYSKENS, F.L., Jr., Retinoids as preventive and therapeutic anti-cancer agents (Part 1). Cancer Treat. Rep., 71, 391-405 (1987).
23. LIU, J., MATHIAS, S., YANG, Z. and KOLESNICK, R.N., Renaturation and tumor necrosis factor-α stimulation of a 97-kDa ceramide activated protein kinase. J. biol. Chem., 269, 3047-3052 (1994).
24. LOVE, J.M. and GUDAS, L.J., Vitamin A, differentiation and cancer. Curr. Opin. Cell. Biol., 6, 825-831 (1994).
25. MOON, R.C. and CONSTANTINOU, A.I., Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis. Breast Cancer Res. Treat., 46, 181-189 (1997).
26. nd ed.), pp. 573-595, Raven Press, New York (1994).
27. NA, S., CHUANG, T.H., CUNNINGHAM, A., TURI, T.G., HANKE, J.H., BOKOCH, G.M. and DANLEY, D.E., D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. biol. Chem. 271, 11209-11213 (1996).
28. NAIK., H.R., KALEKERIAN, G. and PIENTA, K.J., 4-Hydroxyphenylretinamide in the chemoprevention of cancer. Adv. Pharmacol., 33, 315-347 (1995).
29. OBEID, L.M. and HANNUN, Y.A., Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. cell. Biochem., 58, 191-198 (1995).
30. PAGGI, M.G., BALDI, A., BONETTO, F. and GIORDANO, A., Retinoblastoma protein family in cell cycle and cancer: a review. J. cell. Biochem., 62, 418-430 (1996).
31. RILEY, D.J., LEE, E.Y. and LEE, D.W., The retinoblastoma protein: more than a tumor suppressor. Ann. Rev. Cell. Biol., 10, 1-29 (1994).
32. ROBERTSON, K.M., PENLAND, S.N., PADILLA, G.M., SELVAN, R.S., KIM, C.S., FINE, R.L. and ROBERTSON, C.N., Fenretinide: induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cells. Cell Growth Differentiation, 8, 101-111 (1997).
33. SHAH, G.M., SHAH, R.G. and POIRER, G.G., Different cleavage pattern for Poly(ADP-ribose) polymerase during necrosis and apoptosis in HL60 cells. Biochem. biophys. Res. Comm., 229, 838-844 (1996).
34. SPIEGEL, S., FOSTER, D. AND KOLESNICK, R., Signal transduction through lipid second messengers. Curr. Opin. Cell Biol., 8, 159-167 (1996).
35. SPORN, M.B. and ROBERTS, A., Role of retinoids in differentiation and carcinogenesis. J. nat. Cancer Inst., 73, 1381-1385 (1985).
36. WANG, T.T.Y. and PHANG, J.M., Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells. Cancer Lett., 107, 65-71 (1996).
37. WARRELL, R.P. and 12 OTHERS, Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoid acid). N. Engl. J. Med., 324, 1385-1393 (1991).
38. WITTY, J.P., BRIDGHAM, J.T. and JOHNSON, A.L., Induction of apoptotic cell death in hen granulosa cells by ceramide. Endocrinology, 137, 5269-5277 (1996).
39. YANG, Z., COSTANZO, M., GOLDE, D.W. and KOLESNICK R.N., Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J. biol. Chem., 268, 20520-20523 (1993).